Impact of High Disease Burden on Survival in Pediatric Patients with B-ALL Treated with Tisagenlecleucel
Jonas W. Ravich(Johns Hopkins University), Aimee C. Talleur(St. Jude Children's Research Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital), Sujuan Huang(St. Jude Children's Research Hospital), Yinmei Zhou(St. Jude Children's Research Hospital), Challice L. Bonifant(Johns Hopkins University), Stephen Gottschalk(St. Jude Children's Research Hospital), Hiroto Inaba(St. Jude Children's Research Hospital), Patrick A. Brown(Haemonetics (United States)), Cheng Cheng(Jilin University), Brandon M. Triplett(St. Jude Children's Research Hospital)
Cited by 42
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
|Cancer Cell|2002|1.9k
Acute lymphoblastic leukaemia
|The Lancet|2008|1.6k